Wedbush initiated coverage of MannKind (MNKD) with an Outperform rating and $11 price target
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MNKD:
- JMP Securities healthcare analysts hold an analyst/industry conference call
- MannKind Announces Upcoming Retirement of Lauren Sabella
- MannKind initiated with an Overweight at Wells Fargo
- RBC upgrades MannKind on royalty revenue, orphan lung pipeline
- MannKind upgraded to Outperform from Sector Perform at RBC Capital